Breast Cancer News and Research

Latest Breast Cancer News and Research

Report on the global market for breast cancer diagnostics and drug technologies

Breast Cancer Diagnostic and Drug market are recovering after significant slowdown during the global recession. Having accurate market data and analysis will be essential to companies seeking to compete on the global stage as the market reemerges into success.

26 Jun 2012

Metformin reduces overall cancer risk in patients with Type 2 diabetes

A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds. The results will be presented Monday at The Endocrine Society's 94th Annual Meeting in Houston.

26 Jun 2012

Cancer survivors benefit from healthy lifestyle

Australia’s first community-based Cancer Survivors Centre, which is based at the University of New South Wales, has joined the Dry July campaign in a bid to pinpoint the vital role a healthy lifestyle plays in fending off cancer and the after-effects of the disease.

26 Jun 2012

Experimental medication increases muscle strength in cancer patients with low testosterone levels

An experimental medication safely increases muscle strength and physical functioning among cancer patients with low testosterone levels, a new drug study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.

26 Jun 2012

p53 protein may show a typical prion-like behavior when mutated

Prions, the causal agents of Mad Cow and other diseases, are very unique infectious particles. They are proteins in which the complex molecular three-dimensional folding process just went astray. For reasons not yet understood, the misfolding nature of prions is associated to their ability to sequester their normal counterparts and induce them to also adopt a misfolding conformation.

26 Jun 2012

LLUMC suggests check list with six key attributes for successful proton therapy treatment

When a newly diagnosed cancer patient is considering treatment options, proton therapy might not be the first course that comes to mind. Yet over the past two decades proton therapy has continued to evolve as a viable alternative to chemotherapy and a less-invasive procedure than radiation or surgery, so much so that proton therapy is now considered the preferred course of treatment for many doctors and patients in the fight against cancer.

26 Jun 2012

Amgen launches Chemotherapy: Myths or Facts campaign for cancer patients

Amgen today launched Chemotherapy: Myths or Facts, an awareness campaign for cancer patients and their caregivers featuring Emmy-nominated actress and breast cancer survivor Maura Tierney.

26 Jun 2012

Physical activity linked with reduced risk of breast cancer

A new analysis done by University of North Carolina at Chapel Hill researchers has found that physical activity - either mild or intense and before or after menopause - may reduce breast cancer risk, but substantial weight gain may negate these benefits.

25 Jun 2012

Deferasirox reduces elevated iron levels in patients with myelodysplastic syndrome

Researchers at Moffitt Cancer Center and colleagues at six other institutions have recently tested a treatment for patients with myelodysplastic syndrome, or MDS, a blood-related malignancy that involves the ineffective production of blood cells, leaving patients anemic and in need of frequent blood transfusions. Because the body has no natural means to reduce iron that accumulates from repeated transfusions, patients' organs can become iron overloaded, leading to heart failure, liver injury, susceptibility to infection, and other complications.

23 Jun 2012

New paper discusses potential of tumor-derived microvesicles

A new paper by Crislyn D'Souza-Schorey, professor of biological sciences at the University of Notre Dame, discusses the biology of tumor-derived microvesicles and their clinical application as circulating biomarkers. Microvesicles are membrane-bound sacs released by tumor cells and can be detected in the body fluids of cancer patients.

23 Jun 2012

Genentech's Perjeta helps people with HER2-positive metastatic breast cancer live longer

Genentech, a member of the Roche Group, announced today that people with HER2-positive metastatic breast cancer (mBC) lived significantly longer (overall survival) when treated with the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy, compared to Herceptin and docetaxel chemotherapy alone in the Phase III CLEOPATRA study.

23 Jun 2012

FDA advisory panel issues positive opinion for Dune's MarginProbe System

Dune Medical Devices announced today that a U.S. Food and Drug Administration (FDA) Advisory Panel voted (10 to 1) in favor of Dune's MarginProbe System for use in breast cancer surgery, as an adjunct to current standard methods of intraoperative surgical margin assessment.

23 Jun 2012

Novel small-molecule-inhibiting drug stops spread of breast cancer cells

Scientists have developed a small-molecule-inhibiting drug that in early laboratory cell tests stopped breast cancer cells from spreading and also promoted the growth of early nerve cells called neurites.

22 Jun 2012

GBM patients with CNP subtype may have less aggressive subtype of cancer

A diagnosis of glioblastoma multiforme (GBM) is generally a death sentence, but new research from the University of Wisconsin-Madison lab of Dr. John Kuo shows that at least one subtype is associated with a longer life expectancy. This discovery could help with better patient prognoses and lead to targeted drug treatments for GBM subtypes.

21 Jun 2012

Review describes new classes of drugs that target androgens in novel ways

Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives to the traditional methods that frequently carry high side effects.

21 Jun 2012

New robotic device can improve detection of breast cancer

One in eight women in the United States will develop breast cancer over the course of her lifetime. Lorraine G. Olson, professor of mechanical engineering at the Rose-Hulman Institute of Technology in Terre Haute, Indiana, was diagnosed in 2005 at the age of 45. Fortunately, her breast cancer was caught early from a routine mammogram, but like many women, she was prodded by her physician to do the exam.

21 Jun 2012

Value of pathology review highlighted in node-negative breast cancer

Secondary pathology review results in significant changes in diagnosis and treatment for women with node-negative breast cancer, Canadian researchers report.

20 Jun 2012

Inserm researchers examine effect of night work on women’s health

Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France. The risk factors of breast cancer are varied. They include genetic mutations, late first pregnancy, low parity or hormone therapy, but other causes of breast cancer such as way of life, environmental or professional causes have not yet been completely identified.

20 Jun 2012

Bisphosphonate benefit for breast cancer yet to be proven

Older patients with breast cancer may benefit from adjuvant treatment with oral bisphosphonates, but further studies are needed before general application in the breast cancer population, say researchers.

19 Jun 2012

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

19 Jun 2012

Breast Cancer News and Research

Latest Breast Cancer News and Research

Report on the global market for breast cancer diagnostics and drug technologies

Metformin reduces overall cancer risk in patients with Type 2 diabetes

Cancer survivors benefit from healthy lifestyle

Experimental medication increases muscle strength in cancer patients with low testosterone levels

p53 protein may show a typical prion-like behavior when mutated

LLUMC suggests check list with six key attributes for successful proton therapy treatment

Amgen launches Chemotherapy: Myths or Facts campaign for cancer patients

Physical activity linked with reduced risk of breast cancer

Deferasirox reduces elevated iron levels in patients with myelodysplastic syndrome

New paper discusses potential of tumor-derived microvesicles

Genentech's Perjeta helps people with HER2-positive metastatic breast cancer live longer

FDA advisory panel issues positive opinion for Dune's MarginProbe System

Novel small-molecule-inhibiting drug stops spread of breast cancer cells

GBM patients with CNP subtype may have less aggressive subtype of cancer

Review describes new classes of drugs that target androgens in novel ways

New robotic device can improve detection of breast cancer

Value of pathology review highlighted in node-negative breast cancer

Inserm researchers examine effect of night work on women’s health

Bisphosphonate benefit for breast cancer yet to be proven

In Calif. and Mass., reforms proceeding even as court causes uncertainty

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in